Acutaas Chemicals Q1 FY27: net profit up 68% to ₹74.26 crore, revenue up 59%
Acutaas Chemicals (ACUTAAS) said it has published its Q1 FY27 results (consolidated), reporting revenue of ₹330 crore (+59.1% year on year), net profit of ₹74.26 crore (+67.7%), earnings per share of ₹9.07. The company is valued at about ₹29,204 crore.
What happened
In a filing with the BSE on 27 October 2026 at 12:40 PM, Acutaas Chemicals (ACUTAAS) said that it has published its Q1 FY27 results (consolidated), reporting revenue of ₹330 crore (+59.1% year on year), net profit of ₹74.26 crore (+67.7%), earnings per share of ₹9.07.
From the filing: "The Board of Directors of the Company at their meeting held on Friday, October 27, 2026, inter alia, considered & approved Unaudited Standalone & Consolidated Financial Results of the Company ...."
Company snapshot
Acutaas Chemicals is a small-cap company in the Healthcare sector, with a market value of about ₹29,204 crore.
The stock last traded at ₹3,567.1, against a 52-week range of ₹1,570–₹3,740 (4.6% below the high).
Before this filing the shares had moved −3.9% over the month and −6.8% over three months. Average daily turnover over the last 20 sessions was about ₹105 crore.
Promoters held 32.66% at the end of Q1 FY27. Foreign institutions owned 21.61% and domestic institutions 19.56%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 207 | 44.3 | 5.41 |
| Q2 FY26 | 306 | 72.2 | 8.82 |
| Q3 FY26 | 393 | 108 | 13.19 |
| Q4 FY26 | 433 | 131.8 | 16.09 |
| Q1 FY27 | 330 | 74.3 | 9.07 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 2.6% on average the next trading day and was down 10.2% on average after five days (2 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +0.9% on average the next day and +1.9% over five days; 55% of them rose the next day.
Market-wide, 9,766 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 24 Jul 2026 | Results | −2.6% | −10.2% |
| 24 Jul 2026 | Unaudited Standalone And Consolidated Financial Results For First… | −2.6% | −10.2% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 27 October 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Acutaas Chemicals posts 70% profit surge in Q1 FY27 on pharma demand
- Acutaas Chemicals climbs on completing acquisition of 100% stake in Enchem Ami Organics
- Acutaas Chemicals - Ather Energy among 5 stocks showing RSI trending up
- Acutaas Chemicals completes acquisition of Enchem Ami Organics
- Acutaas Chemicals - 10 stocks held by 100+ MF schemes in September rally up to 205% in CY26; 6 turn multibaggers
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.